KMS Medisurgi board to meet on May 30 for FY26 results
KMS Medisurgi Limited will hold a board meeting on May 30, 2026, to approve the standalone audited financial results for the year ended March 31, 2026. The trading window for the company's shares remains closed until 48 hours after the results are disclosed.

*this image is generated using AI for illustrative purposes only.
KMS Medisurgi Limited has announced that its board of directors will meet on Saturday, May 30, 2026, to discuss the company's financial performance for the fiscal year ending March 31, 2026. The meeting is scheduled to take place at 02:00 pm at the registered office located at 297/301, Ground Floor, May Building, Princess Street, Marine Lines (East), Mumbai 400 002.
Agenda for the Meeting
The primary agenda for the upcoming board meeting is to consider and approve the standalone audited financial results for the year ended March 31, 2026. The board will also discuss any other business items with the permission of the chairman.
Trading Window Closure
In accordance with the Company’s Code of Conduct for the prevention of Insider Trading, the trading window for dealing in the equity shares of the company has been closed since April 01, 2026. This restriction will remain in effect until 48 hours after the communication of the financial results to the stock exchanges.
Meeting Details
| Detail | Information |
|---|---|
| Date | May 30, 2026 |
| Time | 02:00 pm |
| Location | Registered Office, Mumbai |
| Purpose | Consideration of FY26 Audited Results |
Historical Stock Returns for KMS Medisurgi
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | +4.98% | +4.65% | +290.59% |
How does KMS Medisurgi's FY26 revenue and profitability compare to its FY25 performance, and what growth trajectory can investors expect going forward?
Will the board announce any dividend distribution or capital allocation plans alongside the FY26 audited results?
How has KMS Medisurgi's stock price reacted historically following its annual results announcements, and what analyst expectations are priced in ahead of this meeting?






























